City of Hope’s mission is to make hope a reality for all touched by cancer and diabetes. Founded in 1913, City of Hope has grown into one of the largest and most advanced cancer research and treatment organizations in the U.S., and one of the leading research centers for diabetes and other life-threatening illnesses. City of Hope research has been the basis for numerous breakthrough cancer medicines, as well as human synthetic insulin and monoclonal antibodies. With an independent, National Cancer Institute-designated comprehensive cancer center that is ranked top 5 in the nation for cancer care by U.S. News & World Report at its core, City of Hope’s uniquely integrated model spans cancer care, research and development, academics and training, and a broad philanthropy program that powers its work. City of Hope’s growing national system includes its Los Angeles campus, a network of clinical care locations across Southern California, a new cancer center in Orange County, California, and cancer treatment centers and outpatient facilities in the Atlanta, Chicago and Phoenix areas. City of Hope’s affiliated group of organizations includes Translational Genomics Research Institute and AccessHopeTM. For more information about City of Hope, follow us on Facebook, X, YouTube, Instagram and LinkedIn. | City of Hope’s mission is to deliver the cures of tomorrow to the people who need them today. Founded in 1913, City of Hope has grown into one of the largest cancer research and treatment organizations in the U.S. and one of the leading research centers for diabetes and other life-threatening illnesses. City of Hope research has been the basis for numerous breakthrough cancer medicines, as well as human synthetic insulin and monoclonal antibodies. With an independent, National Cancer Institute-designated comprehensive cancer center at its core, City of Hope brings a uniquely integrated model to patients spanning cancer care, research and development, academics and training, and innovation initiatives. City of Hope’s growing national system includes its Los Angeles campus, a network of clinical care locations across Southern California, a new cancer center in Orange County, California, and treatment facilities in Atlanta, Chicago and Phoenix. City of Hope’s affiliated group of organizations includes Translational Genomics Research Institute and AccessHopeTM. For more information about City of Hope, follow us on Facebook, Twitter, YouTube, Instagram and LinkedIn. | City of Hope’s mission is to make hope a reality for all touched by cancer and diabetes. Founded in 1913, City of Hope has grown into one of the largest cancer research and treatment organizations in the U.S. and one of the leading research centers for diabetes and other life-threatening illnesses. City of Hope research has been the basis for numerous breakthrough cancer medicines, as well as human synthetic insulin and monoclonal antibodies. With an independent, National Cancer Institute-designated comprehensive cancer center at its core, City of Hope brings a uniquely integrated model to patients spanning cancer care, research and development, academics and training, and innovation initiatives. City of Hope’s growing national system includes its Los Angeles campus, a network of clinical care locations across Southern California, a new cancer center in Orange County, California, and cancer treatment centers and outpatient facilities in the Atlanta, Chicago and Phoenix areas. City of Hope’s affiliated group of organizations includes Translational Genomics Research Institute and AccessHopeTM. For more information about City of Hope, follow us on Facebook, X, YouTube, Instagram and LinkedIn. | City of Hope is a world leader in cancer research, treatment and care. Since 1913, we have been dedicated to making a meaningful impact in the fight against life-threatening illnesses. Accordint o U.S. News and World Report, City of Hope is a top 5 cancer center in the United States and #1 in California. City of Hope’s Charitable Remainder Trust (CRT) program enables agricultural property owners to bypass capital gains tax when selling appreciated property. Additional benefits include creating a new source of lifetime income for the property owner and/or loved ones, a charitable income tax deduction and is a viable succession plan option for those who would like to downsize or retire from the property ownership business. In accordance with the IRS Code, a Charitable Remainder Trust (CRT) is a separate legal and charitable entity. When transferring property into a CRT first, the trust can sell the donated property and bypass capital gains tax at the time of the sale. After the donor’s lifetime, City of Hope will have access to the remaining funds for use towards research, making a difference in the lives of people with cancer, diabetes and other life-threatening illnesses.
Cholangiocarcinoma Foundation
The Cholangiocarcinoma Foundation is a global organization dedicated to curing cholangiocarcinoma (bile duct cancer) and enhancing patients’ quality of life. Through innovative methodologies, partnerships, and support programs, CCF connects patients and caregivers to resources, mentors, and support groups, while also fostering scientific discovery through an annual research fellowship program.
China Anti-Cancer Association
China Anti-Cancer Association (CACA) is a non-governmental and non-profit organization in the field of oncology in China. Founded in 1984, it has developed into the largest organization in cancer field with long history and great influence in China. Up to now, CACA has established local anti-cancer associations in all 31 provinces, cities, and autonomous regions across China, creating a network of 200 professional societies. With 162 organization members and over 800,000 individual members, CACA serves as a significant platform for academic exchanges, public education, promoting CACA Guidelines, and international cooperation in the field of oncology.
cBioPortal for Cancer Genomics
The cBioPortal for Cancer Genomics is a web-based open source software system that provides visualization, analysis and download of large-scale cancer genomics data sets.
CancerTools.org
CancerTools.org is a unique non-profit, cancer-focused research tools supplier and biorepository. As part of Cancer Research UK, we are determined to accelerate and fund cancer discoveries. Our diverse cancer portfolio, deposited from leading academic institutes worldwide includes cell lines, organoids, PDX models, knockout mice, antibodies and reagents for all your research needs. We provide exemplary support to academic and industry partners globally. Our highly cited tools and reagents help drive research success and early drug discovery across all cancer types.
Cancer Center at Illinois
The Cancer Center at Illinois (CCIL) leverages the unique strengths of the University of Illinois Urbana-Champaign in engineering and science to inspire groundbreaking cancer research that transforms cancer detection and treatment for the benefit of all. Led by Phillip and Ann Sharp Director Rohit Bhargava, the CCIL unites over 125 faculty members across two complementary research programs (Cancer Engineering and Biological Systems and Cancer Technology and Data Science) with a shared goal to accelerate and move discoveries to clinical use.
Cancer Research in Germany
Germany is one of the global leaders in the pursuit of understanding, fighting and ultimately eradicating cancer. Supported by funding agencies including the German Research Foundation (DFG), the Alexander von Humboldt Foundation (AvH), the German Academic Exchange Service (DAAD), and the European Research Council (ERC), research organizations such as the German Cancer Research Center (DKFZ), the Tübingen Cluster of Excellence “Image-guided and Functionally Instructed Tumor Therapies” (iFIT), the National Center for Tumor Diseases (NCT) and the German Cancer Consortium (DKTK) are spearheading modern cancer research in Germany, using basic, preclinical and translational research in the development of cancer therapy. Visit us at the “Cancer Research in Germany” booth # 3045 and learn more about your opportunities to help shape the cancer research of tomorrow!
Cancer Science Institute of Singapore, National University of Singapore
Cancer Science Institute of Singapore (CSI Singapore) is hosted by the National University of Singapore (NUS), a globally leading, research-intensive University. Our mission is to better understand the causes of human cancer across Asia, and thereby improve its detection, treatment and prevention. Our outstanding researchers and exceptional facilities create an energetic environment for ground-breaking science and world-class training. Extensive cancer research ranging from basic cancer studies to experimental therapeutics are conducted to improve cancer treatment.
Broad Institute – PRISM Lab
Developed by the Broad Institute of MIT and Harvard, PRISM (Profiling Relative Inhibition Simultaneously in Mixtures) is a novel DNA barcoding technology that allows for rapid, viability screening of more than 900 human cancer cell-line models in mixtures.
ASCO
The American Society of Clinical Oncology, Inc. (the Society) and the Association for Clinical Oncology (the Association) are committed to the principle that knowledge conquers cancer and represent more than 50,000 oncology professionals who care for people living with cancer. Through research, education, and promotion of high quality patient care, our members work to conquer cancer and create a world where cancer is prevented or cured, and every survivor is healthy.